NeuroMetrix, Inc. (NURO)
NASDAQ: NURO · Real-Time Price · USD
4.421
-0.009 (-0.20%)
Mar 31, 2025, 6:03 PM EDT - Market open
NeuroMetrix Employees
NeuroMetrix had 26 employees as of December 31, 2023. The number of employees decreased by 1 or -3.70% compared to the previous year.
Employees
26
Change (1Y)
-1
Growth (1Y)
-3.70%
Revenue / Employee
$144,914
Profits / Employee
-$295,203
Market Cap
9.03M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
NURO News
- 3 months ago - NEUROMETRIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of NeuroMetrix, Inc. - NURO - Business Wire
- 3 months ago - NeuroMetrix to be Acquired by electroCore - GlobeNewsWire
- 8 months ago - NeuroMetrix Reiterates its Review of Strategic Alternatives - GlobeNewsWire
- 8 months ago - NeuroMetrix, Inc. (NURO) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 8 months ago - NeuroMetrix, Inc. Announces Date for Second Quarter 2024 Business Highlights Conference Call - GlobeNewsWire
- 11 months ago - NeuroMetrix Reports Q1 2024 Business Highlights - GlobeNewsWire
- 1 year ago - NeuroMetrix Announces Steps Taken to Enhance Shareholder Value - GlobeNewsWire
- 1 year ago - NeuroMetrix Announces Publication of Study Demonstrating that DPNCheck Accurately Diagnoses Diabetic Peripheral Neuropathy - GlobeNewsWire